{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:12:58Z","timestamp":1790809978322,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1136\/ijgc-2021-002536","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T15:00:46Z","timestamp":1618498846000},"page":"1007-1013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Definitive radiotherapy for vaginal recurrence of early-stage endometrial cancer: survival outcomes and effect of mismatch repair status"],"prefix":"10.1016","volume":"31","author":[{"given":"Gabriela","family":"Alban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Adleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-3434","authenticated-orcid":false,"given":"Ivan","family":"Buzurovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-9055","authenticated-orcid":false,"given":"Larissa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002536_bb0010","unstructured":"American Cancer Society . Key statistics for endometrial cancer. Available: https:\/\/www.cancer.org\/cancer\/endometrial-cancer\/about\/key-statistics.html [Accessed Jan 2021]."},{"key":"10.1136\/ijgc-2021-002536_bb0015","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002536_bb0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0025","author":"Abu-Rustum","year":"2021","journal-title":"National Comprehensive Cancer Network guidelines: uterine neoplasms"},{"key":"10.1136\/ijgc-2021-002536_bb0030","first-page":"403","article-title":"Vaginal and pelvic recurrences in stage I and II endometrial carcinoma--survival and prognostic factors","volume":"32","author":"Blecharz","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0360-3016(88)90110-1","article-title":"Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system","volume":"15","author":"Curran","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002536_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1097-0142(19870801)60:3<419::AID-CNCR2820600323>3.0.CO;2-A","article-title":"Isolated vaginal recurrences of endometrial adenocarcinoma and their management","volume":"60","author":"Greven","year":"1987","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002536_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-8140(02)00212-8","article-title":"Outcome after salvage radiotherapy (brachytherapy +\/- external) in patients with a vaginal recurrence from endometrial carcinomas","volume":"65","author":"Hasbini","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0055","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0360-3016(03)00414-0","article-title":"Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy","volume":"56","author":"Jhingran","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002536_bb0060","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002536_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/gyno.1997.4752","article-title":"Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy","volume":"66","author":"Pai","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ygyno.2005.11.004","article-title":"Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence","volume":"101","author":"Petignat","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0075","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/1097-0142(19940815)74:4<1303::AID-CNCR2820740420>3.0.CO;2-G","article-title":"Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer","volume":"74","author":"Sears","year":"1994","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002536_bb0080","first-page":"241","article-title":"Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy","volume":"33","author":"Sorbe","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2021-002536_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/gyno.2000.5727","article-title":"Results of radical radiotherapy for recurrent endometrial cancer","volume":"77","author":"Wylie","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0090","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.brachy.2017.07.002","article-title":"Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy","volume":"16","author":"Chapman","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002536_bb0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2014.08.038","article-title":"Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification","volume":"113","author":"Vargo","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.brachy.2014.06.004","article-title":"Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer","volume":"13","author":"Fokdal","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002536_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1136\/ijgc-2021-002536_bb0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2018.12.022","article-title":"Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer","volume":"152","author":"Ling","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ygyno.2013.08.040","article-title":"Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer","volume":"131","author":"Lee","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.brachy.2017.07.007","article-title":"MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer","volume":"16","author":"Kamran","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002536_bb0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brachy.2012.11.002","article-title":"Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance","volume":"12","author":"Lee","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002536_bb0130","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijrobp.2012.01.085","article-title":"Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer","volume":"84","author":"Lee","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002536_bb0135","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.2016.67.8722","article-title":"Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG Oncology\/Gynecologic Oncology Group study","volume":"34","author":"McMeekin","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2017.07.003","article-title":"Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival","volume":"146","author":"Cosgrove","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0145","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","article-title":"Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma","volume":"24","author":"Black","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0150","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.2006.08.2107","article-title":"Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type","volume":"25","author":"Zighelboim","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2014.04.053","article-title":"Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type","volume":"134","author":"Ruiz","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002536_bb0160","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/1097-0142(20001015)89:8<1758::AID-CNCR16>3.0.CO;2-A","article-title":"Clinical significance of microsatellite instability in endometrial carcinoma","volume":"89","author":"Basil","year":"2000","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002536_bb0165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.critrevonc.2013.03.002","article-title":"Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis","volume":"88","author":"Diaz-Padilla","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/ijgc-2021-002536_bb0170","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2021-002536_bb0175","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cncr.31901","article-title":"Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: a prognostic biomarker","volume":"125","author":"Backes","year":"2019","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002536_bb0180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ijgc-2019-000910","article-title":"Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers","volume":"30","author":"Kim","year":"2020","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24005218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24005218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:37Z","timestamp":1753223917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24005218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1048891X24005218"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002536","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive radiotherapy for vaginal recurrence of early-stage endometrial cancer: survival outcomes and effect of mismatch repair status","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}